BioCatalyst

RNAC — Cartesian Therapeutics, Inc. catalysts

2 verified catalyst event(s) for Cartesian Therapeutics, Inc. (ticker RNAC). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-11-30 — Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach t · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 4mo
ESTIMATED
 READOUT
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential
Phase 3 · Myasthaenia Gravis
 RNAC Cartesian Therapeutics, Inc. Decartes-08 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12-01
in 4mo
ESTIMATED
 READOUT
Descartes-08 for Patients With Systemic Lupus Erythematosus
Phase 2 · Systemic Lupus Erythematosus (SLE)
 RNAC Cartesian Therapeutics, Inc. Descartes-08 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.